Literature DB >> 17250447

Limited value of vaginal cytology in detecting recurrent disease after radical hysterectomy for early stage cervical carcinoma.

Napat Injumpa1, Prapaporn Suprasert, Jatupol Srisomboon, Kanchana Nimmanahaeminda, Chailert Phongnarisorn, Sitthicha Siriaree, Kittipat Charoenkwan, Chalong Cheewakriangkrai, Chumnan Kietpeerakool.   

Abstract

The objective of this study was to evaluate the value of vaginal cytology in routine surveillance for recurrent cervical cancer after surgery. We reviewed the medical records of 565 patients with stage IB-IIA cervical cancer who were treated with radical hysterectomy and pelvic lymphadenectomy (RHPL) and attended follow- up at Chiang Mai University Hospital between January 2000 and May 2006. With the median follow-up of 35 months (range 1-76 months), 23 (4%) patients developed recurrence. The interval from surgery to detection of recurrence ranged from 5-61 months with a median of 23 months. Of the total 4,376 vaginal smears, 5 (0.1%) showed abnormal cytology but only 1 had malignant cells and tumor recurrence. The sensitivity and specificity of vaginal cytology for detection of recurrence were 4.3% and 99.3%, respectively. In conclusion, vaginal cytology has limited value in detection of recurrence after RHPL for early-stage cervical cancer.

Entities:  

Mesh:

Year:  2006        PMID: 17250447

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  5 in total

1.  Risk factors and clinical aspects of recurrent invasive cervical carcinoma.

Authors:  Fatemeh Ghaemmaghami; Sorayya Saleh-Gargari; Behrokh Sahebdel; Nadereh Behtash; Farhad Samiei
Journal:  J Obstet Gynaecol India       Date:  2012-09-04

2.  Hyaluronic acid binding protein 1 overexpression is an indicator for disease-free survival in cervical cancer.

Authors:  Ming Zhang; Na Li; Yannan Liang; Jinhui Liu; Yafeng Zhou; Chunying Liu
Journal:  Int J Clin Oncol       Date:  2016-12-30       Impact factor: 3.402

3.  Comparative study between liquid-based cytology & conventional Pap smear for cytological follow up of treated patients of cancer cervix.

Authors:  Uma Singh; Sabuhi Qureshi; Neha Negi; Nisha Singh; Madhumati Goel; Kirti Srivastava
Journal:  Indian J Med Res       Date:  2018-03       Impact factor: 2.375

4.  Diagnostic Strategies for Recurrent Cervical Cancer: A Cohort Study.

Authors:  Xiaopei Chao; Junning Fan; Xiaochen Song; Yan You; Huanwen Wu; Ming Wu; Lei Li
Journal:  Front Oncol       Date:  2020-12-07       Impact factor: 6.244

5.  NQO1 overexpression is associated with poor prognosis in squamous cell carcinoma of the uterine cervix.

Authors:  Yue Ma; Jienan Kong; Guanghai Yan; Xiangshan Ren; Dan Jin; Tiefeng Jin; Lijuan Lin; Zhenhua Lin
Journal:  BMC Cancer       Date:  2014-06-09       Impact factor: 4.430

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.